Observation on the clinical efficacy and side effects of EGFR-TKI ± chemotherapy in the treatment of EGFR mutation-positive advanced lung adenocarcinoma,European Journal of Inflammation

当前位置： X-MOL 学术 › Eur. J. Inflamm. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Observation on the clinical efficacy and side effects of EGFR-TKI ± chemotherapy in the treatment of EGFR mutation-positive advanced lung adenocarcinoma
European Journal of Inflammation ( IF 0.7 ) Pub Date : 2022-12-12 , DOI: 10.1177/1721727x221145447
Jianping Zheng ₁ , Tongjian Cui ₁ , Ting Li ₁

Affiliation

ObjectiveTo assess the clinical efficacy and side effects of EGFR-TKI with or without chemotherapy in the treatment of EGFR mutation-positive advanced lung adenocarcinoma.MethodsA total of 103 IIIB...

中文翻译：